Alzheimer's disease is a relentless neurodegenerative condition primarily afflicting older adults, characterized by progressive memory loss, cognitive decline, and behavioral shifts. It stands as the predominant cause of dementia, encompassing a significant majority of cases, between 60% to 80%. This disease gradually erodes brain cells, disrupting neural communication and impairing cognitive functions such as memory recall and everyday task performance.
Initially manifesting as mild forgetfulness and confusion, Alzheimer's advances to severe memory impairment and disorientation with disease progression. While its precise origins remain elusive, factors encompassing genetics, lifestyle, and environment are implicated in its onset. Presently, treatments focus on managing symptoms and enhancing patient quality of life, albeit no definitive cure exists. Ongoing research endeavors are fervently pursued to unlock novel therapies and preventive measures against this widespread and devastating ailment impacting millions globally.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States